Skip to main content Accessibility help
×
Hostname: page-component-745bb68f8f-kw2vx Total loading time: 0 Render date: 2025-01-09T21:13:31.366Z Has data issue: false hasContentIssue false

Chapter 58 - Structural Imaging

from Section 5: - Objectifying Movement Disorders

Published online by Cambridge University Press:  07 January 2025

Erik Ch. Wolters
Affiliation:
Universität Zürich
Christian R. Baumann
Affiliation:
Universität Zürich
Get access

Summary

Clinical diagnosis of movement disorders can be challenging, especially in the early stages of the disease. Therapy and prognosis of the disorders differ markedly, and early diagnosis is desirable. Structural imaging and complementary nuclear imaging can detect characteristic changes in diseases and present an objective, reproducible opportunity to confirm the suspected diagnosis, sometimes before the disease reaches its clinical full-blown stage. Differential diagnoses may also be excluded. After an introduction of the imaging methods, we present structural changes of a typical Parkinson syndrome as seen in sporadic Parkinson’s disease and some familial mono-/oligo-/polygenic and intermediate genetic variants, such as the "swallow tail sign." Characteristic features of atypical parkinsonian syndromes (MSA, PSP, CBD and vascular parkinsonism) are also presented and extended to include nuclear medicine aspects. Imaging features are classified in terms of their importance for diagnosis and differential diagnosis. Image examples are given to illustrate the features and the most important features and differential diagnoses are summarized and presented in tables.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Saeed, U, Compagnone, J, Aviv, RI, et al. Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener 2017;6(1):125.CrossRefGoogle ScholarPubMed
Ghadery, C, Strafella, AP. New imaging markers for movement disorders. Curr Neurol Neurosci Rep 2018;18(5):22.CrossRefGoogle ScholarPubMed
Reiter, E, Mueller, C, Pinter, B, et al. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism. Mov Disord 2015;30(8):10681076.CrossRefGoogle ScholarPubMed
Schwarz, ST, Afzal, M, Morgan, PS, et al. The “swallow tail” appearance of the healthy nigrosome – a new accurate test of Parkinson’s disease: a case–control and retrospective cross-sectional MRI study at 3T. PLoS One 2014;9(4):e93814.CrossRefGoogle Scholar
Mahlknecht, P, Krismer, F, Poewe, W, Seppi, K. Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson’s disease. Mov Disord 2017;32(4):619623.CrossRefGoogle ScholarPubMed
Marek, K, Seibyl, J, Eberly, S, et al. Longitudinal follow-up of SWEDD subjects in the PRECEPT Study. Neurology 2014;82(20):17911797.CrossRefGoogle ScholarPubMed
Chelban, V, Bocchetta, M, Hassanein, S, et al. An update on advances in magnetic resonance imaging of multiple system atrophy. J Neurol 2019;266(4):10361045.CrossRefGoogle ScholarPubMed
Brooks, DJ, Seppi, K, Neuroimaging Working Group on MSA. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 2009;24(7):949964.CrossRefGoogle ScholarPubMed
Feng, J-Y, Huang, B, Yang, W-Q, et al. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson’s disease? Acta Radiol 2015;56(3):322328.CrossRefGoogle ScholarPubMed
Hwang, I, Sohn, CH, Kang, KM, et al. Differentiation of parkinsonism-predominant multiple system atrophy from idiopathic Parkinson disease using 3T susceptibility-weighted MR imaging, focusing on putaminal change and lesion asymmetry. Am J Neuroradiol 2015;36(12):22272234.CrossRefGoogle ScholarPubMed
Matsusue, E, Fujii, S, Kanasaki, Y, et al. Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology 2008;50(7):559567.CrossRefGoogle ScholarPubMed
Lee, W-H, Lee, C, Shyu, W, Chong, P, Lin, S. Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T. Am J Neuroradiol 2005;26(9):22382242.Google Scholar
Rizzo, G, Martinelli, P, Manners, D, et al. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson’s disease. Brain 2008;131(10):26902700.CrossRefGoogle ScholarPubMed
Okamoto, K, Tokiguchi, S, Furusawa, T, et al. MR features of diseases involving bilateral middle cerebellar peduncles. Am J Neuroradiol 2003;24(10):19461954.Google ScholarPubMed
Ling, H. Clinical approach to progressive supranuclear palsy. J Mov Disord 2016;9(1):313.CrossRefGoogle ScholarPubMed
Haller, S, Garibotto, V, Schwarz, S. Neuroimaging in movement disorders. In: Barkhof, F, Jager, R, Thurnher, M, Rovira Cañellas, A, eds. Clinical Neuroradiology. Cham: Springer; 2018: 175184.Google Scholar
Gröschel, K, Kastrup, A, Litvan, I, Schulz, JB. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology 2006;66(6):949950.CrossRefGoogle ScholarPubMed
Massey, LA, Jäger, HR, Paviour, DC, et al. The midbrain to pons ratio. Neurology 2013;80:18561861.CrossRefGoogle ScholarPubMed
Josephs, KA. Frontotemporal lobar degeneration. Neurol Clin 2007;25(3):683696.CrossRefGoogle ScholarPubMed
Adachi, M, Kawanami, T, Ohshima, H, Sugai, Y, Hosoya, T. Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magnet Res Med Sci 2004;3(3):125132.CrossRefGoogle ScholarPubMed
Tokumaru, AM, O’uchi, T, Kuru, Y, et al. Corticobasal degeneration: MR with histopathologic comparison. Am J Neuroradiol 1996;17(10):18491852.Google ScholarPubMed
Ma, KKY, Lin, S, Mok, VCT. Neuroimaging in vascular parkinsonism. Curr Neurol Neurosci Rep 2019;19(12):110.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×